TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Genzyme Corporation Investor Files Lawsuit Against Board of Directors

  • If you are an investor in Genzyme Corporation (NASDAQ:GENZ) shares, who purchased GENZ prior to July 23, 2010, and/or you have any information relating the investigation, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

MARCH 2012 - Case dismissed. An investor in Genzyme Corporation (NASDAQ:GENZ) filed a lawsuit in Federal Court against the board of directors of Genzyme Corp. alleging breaches of fiduciary duty in connection with the proposed takeover of Genzyme by Sanofi Aventis SA. On Sunday, August 29, 2010, the French drug developer Sanofi-Aventis offered $69 a share for Genzyme. The following ...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: